This report is built using data and information sourced from Global Markets Direct's proprietary databases, Medicis
Pharmaceutical Corporation's corporate website, SEC filings, investor presentations and featured press releases, both from Medicis
Pharmaceutical Corporation and industry-specific third party sources, put together by Global Markets Direct's team.
Ipsen Group had signed an agreement with the Medicis
Group (USA) in March 2006 granting Medicis
the exclusive right to develop, sell and market certain formulations of botulinum toxin type A for use in aesthetic medicine indications approved in the US and Canada.
In September, Valeant had finalized a deal to purchase Medicis
The acquisition of Medicis
represents a significant next step in our journey to become the leader in dermatology," Valeant chief executive Michael Pearson said in a statement.
2m) convertible notes offer of US speciality pharmaceutical firm Medicis
Pharmaceutical Corp (NYSE:MRX), the company said.
Through the acquisition, Solta will bolster its aesthetics solutions portfolio by adding Medicis
Technologiesa[euro](tm) Liposonix fat destruction system, the company said.
has filed a lawsuit against Medicis
In an unusual deal, the importer of a 600-year-old line of cologne originally created for the 16th century Queen of France Catherine de Medicis
has secured one of the few remaining warehouse spaces in SoHo.
With the pick of Renaissance art at their command, what did the Medicis
choose to look at when they were at home?
2m from the US company Medicis
in connection with Medicis
' acquisition of Q-Med's subsidiary HA North American Sales AB.
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Medicis
Pharmaceutical Corporation ("Medicis
" or the "Company") (NYSE-MRX) relating to the proposed acquisition by Valeant Pharmaceutical.
Pharmaceutical Corp is acquired by Canadian drugmaker Valeant Pharmaceuticals International, Inc.
M2 EQUITYBITES-May 11, 2012--Deutsche Bank Securities, JP Morgan Securities handle Medicis
note offer(C)2012 M2 COMMUNICATIONS http://www.
22 November 2011 - US speciality pharmaceutical firm Medicis
(NYSE:MRX) said late last week it had won a bankruptcy auction for substantially all of the outstanding US and Canadian pharmaceutical assets of Graceway Pharmaceuticals LLC, the US sector player that filed for Chapter 11 bankruptcy protection on 29 September this year.
Canada's drug maker Valeant Pharmaceuticals (TSE:VRX) is said to have approached US Medicis
Pharmaceutical (NYSE:MRX) over a potential takeover, the Wall Street Journal said, quoting sources in the know.